Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

No treatment fully stops excessive hair growth in women, but various methods can help manage it effectively.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

No clear link between pilonidal sinus disease and polycystic ovary syndrome was found.

Women with different PCOS types have similar fertility treatment results.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.